Total Payments
$263,014
2024 Payments
$39,560
Companies
26
Transactions
274
Medicare Patients
859
Medicare Billing
$189,524
Payment Breakdown by Category
Other$215,585 (82.0%)
Consulting$21,181 (8.1%)
Travel$18,172 (6.9%)
Food & Beverage$7,692 (2.9%)
Education$384.36 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $98,570 | 40 | 37.5% |
| Honoraria | $74,980 | 18 | 28.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $42,035 | 21 | 16.0% |
| Consulting Fee | $21,181 | 7 | 8.1% |
| Travel and Lodging | $18,172 | 67 | 6.9% |
| Food and Beverage | $7,692 | 115 | 2.9% |
| Education | $384.36 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $87,072 | 71 | $0 (2024) |
| Karyopharm Therapeutics Inc. | $82,821 | 63 | $0 (2024) |
| Aveo Pharmaceuticals, Inc. | $76,923 | 77 | $0 (2024) |
| Mirati Therapeutics, Inc. | $11,661 | 13 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $1,605 | 3 | $0 (2024) |
| LEICA MICROSYSTEMS INC. | $773.94 | 1 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $465.46 | 4 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $403.26 | 9 | $0 (2023) |
| Amgen Inc. | $239.38 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $173.83 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,560 | 45 | Aveo Pharmaceuticals, Inc. ($30,343) |
| 2023 | $75,126 | 67 | Karyopharm Therapeutics Inc. ($32,403) |
| 2022 | $96,891 | 92 | Karyopharm Therapeutics Inc. ($49,571) |
| 2021 | $27,472 | 32 | GENZYME CORPORATION ($24,628) |
| 2020 | $16,007 | 15 | GENZYME CORPORATION ($15,966) |
| 2019 | $6,117 | 10 | GENZYME CORPORATION ($6,017) |
| 2018 | $1,285 | 6 | LEICA MICROSYSTEMS INC. ($773.94) |
| 2017 | $556.49 | 7 | Alexion Pharmaceuticals, Inc. ($465.46) |
All Payment Transactions
274 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | Cash or cash equivalent | $76.00 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | Cash or cash equivalent | $100.68 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | Cash or cash equivalent | $78.18 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | Cash or cash equivalent | $63.31 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: CELLT | ||||||
| 11/06/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,943.00 | General |
| Category: Oncology | ||||||
| 11/06/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $86.17 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $5,445.00 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,420.00 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | In-kind items and services | $839.26 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | In-kind items and services | $639.46 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | In-kind items and services | $145.77 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.17 | General |
| 10/15/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $535.00 | General |
| Category: Oncology | ||||||
| 10/12/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | In-kind items and services | $338.86 | General |
| Category: Oncology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $33.63 | General |
| 10/03/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $5,445.00 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,210.00 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | Cash or cash equivalent | $314.36 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | Cash or cash equivalent | $30.95 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: NONE | ||||||
| 09/14/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | In-kind items and services | $316.46 | General |
| Category: Oncology | ||||||
| 09/14/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Travel and Lodging | In-kind items and services | $177.56 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,513.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 266 | 492 | $137,895 | $64,697 |
| 2022 | 5 | 249 | 366 | $108,436 | $52,206 |
| 2021 | 4 | 169 | 268 | $104,667 | $33,832 |
| 2020 | 4 | 175 | 355 | $135,985 | $38,788 |
Total Patients
859
Total Services
1,481
Medicare Billing
$189,524
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 261 | $71,253 | $38,024 | 53.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 126 | $30,996 | $12,387 | 40.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 57 | 57 | $24,339 | $9,825 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,107 | $2,832 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 25 | $4,200 | $1,629 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 76 | 165 | $45,045 | $25,173 | 55.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 85 | 85 | $36,295 | $15,292 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 68 | $16,728 | $7,077 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $9,270 | $4,162 | 44.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 15 | 18 | $1,098 | $502.02 | 45.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 64 | 147 | $61,756 | $19,739 | 32.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 54 | 67 | $21,537 | $7,255 | 33.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 24 | 24 | $11,806 | $4,371 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 30 | $9,568 | $2,468 | 25.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 85 | 237 | $99,852 | $28,309 | 28.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 63 | $19,539 | $4,721 | 24.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 33 | 42 | $9,180 | $3,766 | 41.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 13 | 13 | $7,414 | $1,992 | 26.9% |
About Dr. Hardeep Phull, MD
Dr. Hardeep Phull, MD is a Internal Medicine healthcare provider based in Escondido, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1306103510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hardeep Phull, MD has received a total of $263,014 in payments from pharmaceutical and medical device companies, with $39,560 received in 2024. These payments were reported across 274 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($98,570).
As a Medicare-enrolled provider, Phull has provided services to 859 Medicare beneficiaries, totaling 1,481 services with total Medicare billing of $189,524. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Escondido, CA
- Active Since 04/12/2012
- Last Updated 02/01/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1306103510
Products in Payments
- XPOVIO (Drug) $82,821
- FOTIVDA (Drug) $76,923
- SARCLISA (Biological) $57,015
- ELITEK (Biological) $19,772
- KRAZATI (Drug) $11,661
- ELITEK (Drug) $6,017
- JEVTANA (Drug) $1,779
- LIBTAYO (Biological) $1,605
- DIGITAL MICROSCOPES (Device) $773.94
- SOLIRIS (Drug) $465.46
- OPDIVO (Biological) $206.09
- DARZALEX (Biological) $185.72
- LYNPARZA (Drug) $122.40
- BLENREP (Biological) $121.11
- TAZVERIK (Drug) $119.01
- Orserdu (Drug) $86.01
- Enhertu (Drug) $50.91
- Kyprolis (Drug) $47.41
- XT CDX (Device) $43.28
- IBRANCE (Drug) $42.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Escondido
Christopher Vanichsarn, M.d, M.D
Internal Medicine — Payments: $11,595
Internal Medicine $11,595
Dr. Vasken Keleshian, Md, MD
Internal Medicine — Payments: $10,387
Internal Medicine $10,387
Lara Le, Md, MD
Internal Medicine — Payments: $8,834
Internal Medicine $8,834
Kandan Baban, D.o, D.O
Internal Medicine — Payments: $5,068
Internal Medicine $5,068
Alan Chang, M.d, M.D
Internal Medicine — Payments: $3,748
Internal Medicine $3,748
James Otoshi, M.d, M.D
Internal Medicine — Payments: $3,738
Internal Medicine $3,738